$CLVT earnings report

Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation. AlphAI read Clarivate's Third Quarter 2026 filing as mixed. 2 quarters are on record below.

Third Quarter 2026

AlphAI · Earnings readCLVT · Third Quarter 2026 · ended September 30, 2026

Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation

→Mixed quarter

Continuing-operations organic revenue grew 0.4% and organic ACV grew 1.8%, while total continuing-operations revenue declined 9.2% because of disposals. Adjusted EBITDA margin expanded to 45.3%, but GAAP net loss widened and free cash flow declined.

Revenue
$568M
(8.9)% y/y
Academia & Government, three months ended September 30, 2026
$287M
(13.7)% y/y
EPS · non-GAAP
$0.21
16.7% y/y
Full Year 2026 Outlook and Q4 2026 Outlook, excluding discontinued operations except as specified in the release outlook
Full Year 2026: $1.965B to $1.985B; Q4 2026: $490M to $510M

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Three months ended September 30, 2026 revenues, including discontinued operationsGAAP$567.9M–(8.9)%
Three months ended September 30, 2026 revenues, continuing operationsGAAP$481.6M–(9.2)%
Three months ended September 30, 2026 organic revenues, continuing operationsother0.4%–0.4%
Three months ended September 30, 2026 organic ACV, continuing operationsother1.8%–1.8%
Three months ended September 30, 2026 total ACV growthother3.6%–3.6%
Three months ended September 30, 2026 subscription revenues, continuing operationsGAAP$338.3M–0.7%
Three months ended September 30, 2026 organic subscription revenue growthother1.5%–1.5%
Three months ended September 30, 2026 re-occurring revenues, continuing operationsGAAP$105.8M–0.5%
Three months ended September 30, 2026 organic re-occurring revenue growthother0.7%–0.7%
Three months ended September 30, 2026 recurring revenues, continuing operationsGAAP$444.1M–0.7%
Three months ended September 30, 2026 organic recurring revenue growthother1.3%–1.3%
Three months ended September 30, 2026 transactional revenues, continuing operationsGAAP$37.5M–(57.9)%
Three months ended September 30, 2026 organic transactional revenue growthother(12.4)%–(12.4)%
Three months ended September 30, 2026 cost of revenues, continuing operationsGAAP$139M––
Three months ended September 30, 2026 selling, general and administrative costs, continuing operationsGAAP$134.6M––
Three months ended September 30, 2026 depreciation and amortization, continuing operationsGAAP$162.3M––
Three months ended September 30, 2026 restructuring costs, continuing operationsGAAP$4.5M––
Three months ended September 30, 2026 total operating expenses, continuing operationsGAAP$441.5M––
Three months ended September 30, 2026 operating income, continuing operationsGAAP$40.1M––
Three months ended September 30, 2026 income loss from continuing operations, net of taxesGAAP−$26.4M––
Three months ended September 30, 2026 net loss, including discontinued operationsGAAP$80.8M–N/M
Three months ended September 30, 2026 diluted EPS, continuing operationsGAAP$ (0.04)––%
Three months ended September 30, 2026 diluted EPS, discontinued operationsGAAP$ (0.09)–N/M
Three months ended September 30, 2026 diluted EPS, including discontinued operationsGAAP$ (0.13)–N/M
Three months ended September 30, 2026 adjusted net income, including discontinued operationsnon-GAAP$136M–14.0%
Three months ended September 30, 2026 adjusted diluted EPS, including discontinued operationsnon-GAAP$0.21–16.7%
Three months ended September 30, 2026 adjusted EBITDA, continuing operationsnon-GAAP$218.2M–(1.8)%
Three months ended September 30, 2026 adjusted EBITDA margin, continuing operationsnon-GAAP45.3%––
Three months ended September 30, 2026 adjusted EBITDA, including discontinued operationsnon-GAAP$245.3M–(2.8)%
Three months ended September 30, 2026 adjusted EBITDA margin, including discontinued operationsnon-GAAP43.2%––
Three months ended September 30, 2026 net cash provided by operating activities, including discontinued operationsGAAP$165.6M–(8.6)%
Three months ended September 30, 2026 free cash flow, including discontinued operationsnon-GAAP$110.2M–(4.6)%
Nine months ended September 30, 2026 revenues, including discontinued operationsGAAP$1.74B–(5.3)%
Nine months ended September 30, 2026 revenues, continuing operationsGAAP$1.47B–(4.8)%
Nine months ended September 30, 2026 organic revenues, continuing operationsother0.1%–0.1%
Nine months ended September 30, 2026 recurring revenues, continuing operationsGAAP$1.33B–1.4%
Nine months ended September 30, 2026 organic recurring revenue growthother0.9%–0.9%
Nine months ended September 30, 2026 net loss, including discontinued operationsGAAP$389.6M–N/M
Nine months ended September 30, 2026 adjusted net income, including discontinued operationsnon-GAAP$378.4M–11.8%
Nine months ended September 30, 2026 adjusted diluted EPS, including discontinued operationsnon-GAAP$0.59–20.4%
Nine months ended September 30, 2026 adjusted EBITDA, continuing operationsnon-GAAP$645.6M–(0.1)%
Nine months ended September 30, 2026 adjusted EBITDA margin, continuing operationsnon-GAAP43.8%––
Nine months ended September 30, 2026 adjusted EBITDA, including discontinued operationsnon-GAAP$733.7M–(1.8)%
Nine months ended September 30, 2026 net cash provided by operating activities, including discontinued operationsGAAP$399M–(14.9)%
Nine months ended September 30, 2026 capital expendituresGAAP−$165.9M––
Nine months ended September 30, 2026 free cash flow, including discontinued operationsnon-GAAP$233.1M–(15.6)%
Cash and cash equivalents, including restricted cash, as of September 30, 2026GAAP$257M––
Total debt outstanding as of September 30, 2026GAAP$4.18B––

Segments

SegmentRevenueq/qy/y
Academia & Government, three months ended September 30, 2026Organic revenue growth was 0.9%; disposals contributed (14.1)% and FX contributed (0.5)%.$286.9M–(13.7)%
Intellectual Property, three months ended September 30, 2026Organic revenue growth was (0.4)%; disposals contributed (0.6)% and FX contributed (0.6)%.$194.7M–(1.6)%
Academia & Government, nine months ended September 30, 2026Organic revenue growth was 1.1%; disposals contributed (8.9)% and FX contributed 0.3%.$882.2M–(7.5)%
Intellectual Property, nine months ended September 30, 2026Organic revenue growth was (1.3)%; disposals contributed (0.3)% and FX contributed 1.1%.$590.2M–(0.5)%

Full Year 2026 Outlook and Q4 2026 Outlook, excluding discontinued operations except as specified in the release outlook

  • RevenueFull Year 2026: $1.965B to $1.985B; Q4 2026: $490M to $510M
  • NoteACV Organic Growth: Full Year 2026 1.75% to 2.25%; Q4 2026 1.75% to 2.25%.
  • NoteRecurring Organic Revenue Growth: Full Year 2026 1.00% to 1.50%; Q4 2026 2.00% to 2.50%.
  • NoteAdjusted EBITDA: Full Year 2026 $0.865B to $0.885B; Q4 2026 $215M to $235M.
  • NoteAdjusted EBITDA Margin: Full Year 2026 43.0% to 45.0%; Q4 2026 44.0% to 46.0%.
  • NoteAdjusted Diluted EPS: Full Year 2026 $0.73 to $0.77; Q4 2026 $0.14 to $0.18.
  • NoteFree Cash Flow: Full Year 2026 $320M to $340M; Q4 2026 $85M to $105M.
  • NoteFull year 2026 Adjusted diluted EPS includes results from discontinued operations for the nine months ended September 30, 2026 and excludes results from discontinued operations for the three months ended December 31, 2026.
  • NoteFull year 2026 Free cash flow includes results from discontinued operations for the nine months ended September 30, 2026 and excludes results from discontinued operations for the three months ended December 31, 2026.

Capital returns

  • Repurchases of ordinary shares were $18.1 million during the nine months ended September 30, 2026, compared to $149.5 million during the nine months ended September 30, 2025.
  • Principal payments on debt were $284.2 million during the nine months ended September 30, 2026.
  • A $100.0 million accelerated debt repayment in January 2026 resulted in the full redemption of the senior secured notes due November 2026.
  • The company retired $192.6 million aggregate principal of senior secured notes due 2028 and senior notes due 2029 through debt repurchases at an approximate 5% discount to par.

What drove it

  • Organic subscription revenue increased 1.5%, primarily due to new sales and pricing actions.
  • Organic re-occurring revenue increased 0.7%, primarily due to higher IP volumes.
  • Organic transactional revenue declined 12.4%, primarily due to lower activity across both segments and customer migration to higher margin subscription products.
  • Organic ACV growth of 1.8% was primarily driven by improved product pricing.
  • Third-quarter continuing-operations adjusted EBITDA margin was 45.3%, compared to 41.9% in the prior-year quarter.
  • The third-quarter net loss included a $62.2 million non-cash LS&H goodwill impairment charge.

Concerns

  • Continuing-operations revenue declined 9.2% year over year, primarily due to inorganic disposals.
  • Intellectual Property organic revenue declined (0.4)% in the third quarter and (1.3)% in the first nine months.
  • Transactional revenue declined $51.6 million, or (57.9)%, in the third quarter.
  • Nine-month free cash flow declined (15.6)% year over year.
  • Net loss including discontinued operations widened to $80.8 million in the third quarter and $389.6 million in the first nine months.
  • Total debt outstanding was $4,176.1 million as of September 30, 2026.

What to watch

  • Q4 2026 recurring organic revenue growth outlook of 2.00% to 2.50%.
  • Q4 2026 ACV organic growth outlook of 1.75% to 2.25%.
  • Q4 2026 revenue outlook of $490M to $510M and adjusted EBITDA outlook of $215M to $235M.
  • Q4 2026 free cash flow outlook of $85M to $105M.
  • Progress translating AI-led innovation and product pricing into sustained organic growth.
  • Use of the $488.4 million in net cash proceeds from the LS&H sale and further debt reduction.

Balance sheet and cash flow

  • Cash and cash equivalents, including restricted cash, were $257.0 million as of September 30, 2026, compared to $329.2 million as of December 31, 2025.
  • Total debt outstanding was $4,176.1 million as of September 30, 2026, a decrease of $293.8 million compared to the prior year.
  • Long-term debt was $4,136.8 million as of September 30, 2026, compared to $4,321.5 million as of December 31, 2025.
  • On October 6, 2026, the company completed the sale of the LS&H segment for net cash proceeds of $488.4 million.
  • Nine-month operating cash flow was $399.0 million, compared to $468.6 million in the prior-year period.
  • Nine-month free cash flow was $233.1 million, compared to $276.1 million in the prior-year period.

Analysis

Clarivate reported $481.6 million of third-quarter continuing-operations revenue, down (9.2)% from $530.3 million, as inorganic disposals reduced reported revenue. Underlying growth was positive but limited: organic revenue increased 0.4%, organic subscription revenue increased 1.5%, organic re-occurring revenue increased 0.7%, and organic ACV grew 1.8%. Transactional revenue was the major offset, falling $51.6 million to $37.5 million, with a (12.4)% organic decline attributed to lower activity and customer migration toward higher-margin subscription products.

The segment picture remained uneven. Academia & Government generated $286.9 million of revenue, down (13.7)% on a reported basis but up 0.9% organically. Intellectual Property generated $194.7 million, down (1.6)% reported and down (0.4)% organically. Management cited a return to positive ACV growth in Intellectual Property, while the supplemental disclosure attributes company organic ACV growth primarily to improved product pricing.

Profitability improved on a continuing-operations adjusted basis despite the revenue decline. Adjusted EBITDA was $218.2 million, down (1.8)%, while adjusted EBITDA margin expanded to 45.3% from 41.9%. GAAP operating income was $40.1 million versus $45.9 million, and the continuing-operations net loss was $26.4 million versus $24.9 million. Including discontinued operations, net loss was $80.8 million, compared with $28.3 million, driven by a $62.2 million non-cash LS&H goodwill impairment charge. Adjusted net income increased to $136.0 million and adjusted diluted EPS increased to $0.21.

Cash generation declined during the first nine months. Operating cash flow was $399.0 million versus $468.6 million and free cash flow was $233.1 million versus $276.1 million. The company reported $257.0 million of cash and cash equivalents, including restricted cash, and $4,176.1 million of total debt outstanding at September 30. It repurchased $18.1 million of ordinary shares during the first nine months and completed the LS&H sale on October 6 for $488.4 million of net cash proceeds.

The updated outlook reflects the LS&H divestiture. Clarivate guided for full-year revenue of $1.965B to $1.985B, adjusted EBITDA of $0.865B to $0.885B, adjusted EBITDA margin of 43.0% to 45.0%, adjusted diluted EPS of $0.73 to $0.77, and free cash flow of $320M to $340M. For Q4, the company guided for recurring organic revenue growth of 2.00% to 2.50%, revenue of $490M to $510M, adjusted EBITDA of $215M to $235M, and free cash flow of $85M to $105M. The central execution issue is whether the improving subscription, recurring revenue and ACV trends can offset continued weakness in transactional revenue and produce the guided acceleration in Q4.

Management, verbatim

Third quarter results continued to improve across key metrics, including organic recurring revenue growth and the return to positive ACV growth in the Intellectual Property segment.

Matti Shem Tov, Chief Executive Officer

The growing commercial traction and customer validation from our AI-led innovation within A&G and IP give us confidence in our ability to deliver on our commitments of accelerating sustained organic growth, expanding free cash flow and reducing leverage.

Matti Shem Tov, Chief Executive Officer

We are seeing the benefits of disciplined execution across the business, with improving growth trends, strong margins and continued free cash flow generation.

Michael Easton, Executive Vice President and Chief Financial Officer

Not in the filing

stated, not guessed
  • GAAP gross margin was not reported.
  • GAAP or non-GAAP gross-margin guidance was not reported.
  • Forward operating-expense guidance was not reported.
  • Forward tax-rate guidance was not reported.
  • A prior-quarter comparison was not reported for the disclosed quarterly metrics.
  • A quarterly balance-sheet comparison to September 30, 2025 for cash and total debt was not reported.
  • The previous outlook covered the full year 2026 only, so there is nothing to compare for this quarter.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Second Quarter 2026

AlphAI · Earnings readCLVT · Second Quarter 2026 · ended June 30, 2026

Clarivate Reports Second Quarter 2026 Results — Delivers continued progress on strategic and financial priorities through Value Creation Plan

→Mixed quarter

Organic subscription and ACV growth, adjusted diluted EPS growth, debt reduction, and reaffirmed full-year outlook were offset by lower reported revenue, lower Adjusted EBITDA, lower operating cash flow and free cash flow, and a larger GAAP net loss driven by a $221.7 million non-cash goodwill impairment charge.

Revenue
$587M
(5.5)% y/y
Subscription revenues
$403M
0.6% y/y
EPS · non-GAAP
$0.19
5.6% y/y
Full Year 2026 outlook
$2.30B to $2.42B

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Total revenuesGAAP$587.3M–(5.5)%
Organic revenuesother(1.5)%–(1.5)%
Organic subscription growthother0.7%–0.7%
Organic ACV growthother1.5%–1.5%
Net lossGAAP$268.6M–N/M
Diluted EPSGAAP$0.42 per diluted share–N/M
Adjusted net incomenon-GAAP$123.1M–(0.2)%
Adjusted diluted EPSnon-GAAP$0.19 per diluted share–5.6%
Adjusted EBITDAnon-GAAP$247.2M–(5.5)%
Net cash provided by operating activitiesGAAP$98.7M–(15.1)%
Free cash flownon-GAAP$44M–(12.5)%
Total revenues, first six months of 2026GAAP$1.17B–(3.5)%
Organic revenues, first six months of 2026other(0.4)%–(0.4)%
Organic recurring revenues growth, first six months of 2026other0.7%–0.7%
Net loss, first six months of 2026GAAP$308.8M–(75.6)%
Diluted EPS, first six months of 2026GAAP$0.48 per diluted share–(84.6)%
Adjusted net income, first six months of 2026non-GAAP$242.4M–10.6%
Adjusted diluted EPS, first six months of 2026non-GAAP$0.38 per diluted share–18.8%
Adjusted EBITDA, first six months of 2026non-GAAP$488.4M–(1.3)%
Net cash provided by operating activities, first six months of 2026GAAP$233.4M–(18.8)%
Free cash flow, first six months of 2026non-GAAP$122.9M–(23.5)%

Segments

SegmentRevenueq/qy/y
Subscription revenuesPrimarily due to product group wind-downs within LS&H; organic subscription revenues increased 0.7%, primarily due to new sales and price increases.$403.3M–0.6%
Re-occurring revenuesPrimarily due to foreign exchange benefit.$109.3M–0.4%
Transactional revenuesPrimarily due to product group wind-downs within A&G. Organic transactional revenues decreased 15.7%, primarily due to lower activity across all segments, driven in part by customer migrations to subscription offerings.$74.7M–(30.1)%

Full Year 2026 outlook

  • Revenue$2.30B to $2.42B
  • NoteACV Organic Growth: 2.0% to 3.0%
  • NoteRecurring Organic Revenue Growth: 0.75% to 2.25%
  • NoteAdjusted EBITDA: $980M to $1.04B
  • NoteAdjusted EBITDA Margin: 42.0% to 43.5%
  • NoteAdjusted Diluted EPS: $0.70 to $0.80
  • NoteFree Cash Flow: $365M to $435M
  • NoteThe full year outlook assumes no further acquisitions, divestitures, or unanticipated events.

What drove it

  • Reported revenue declines were primarily due to inorganic divestitures and disposals.
  • Organic subscription revenue growth was driven primarily by new sales and price increases.
  • Organic ACV grew 1.5% compared to June 30, 2025.
  • Recurring revenues increased 0.5% organically.
  • Lower organic transactional revenues reflected lower activity across all segments and customer migrations to subscription offerings.
  • The GAAP net loss was driven by a $221.7 million non-cash goodwill impairment charge.
  • The Company cited the previously announced divestiture of the Life Sciences & Healthcare segment as creating a more focused company with greater financial flexibility and a higher recurring revenue mix.

Concerns

  • Organic revenues decreased 1.5% in the second quarter and 0.4% in the first six months of 2026.
  • Transactional revenues decreased $32.1 million, or 30.1%, to $74.7 million, while organic transactional revenues decreased 15.7%.
  • Second-quarter Adjusted EBITDA decreased $14.4 million, or 5.5%, to $247.2 million.
  • First-half operating cash flow and free cash flow declined from the prior-year period.
  • GAAP net loss widened to $268.6 million in the second quarter, driven by the $221.7 million non-cash goodwill impairment charge.
  • Full-year outlook assumes no further acquisitions, divestitures, or unanticipated events.

What to watch

  • Progress toward full-year ACV Organic Growth of 2.0% to 3.0%.
  • Progress toward full-year Recurring Organic Revenue Growth of 0.75% to 2.25%.
  • The trajectory of organic transactional revenues and customer migrations to subscription offerings.
  • Execution of the Life Sciences & Healthcare segment divestiture and the anticipated impact on the Company's financial profile.
  • Delivery against full-year Adjusted EBITDA of $980M to $1.04B and Free Cash Flow of $365M to $435M.
  • Continued debt reduction and use of proceeds from the Life Sciences & Healthcare divestiture.

Balance sheet and cash flow

  • Cash and cash equivalents of $217.7 million as of June 30, 2026, decreased $111.5 million compared to December 31, 2025.
  • Total debt outstanding was $4,251.5 million as of June 30, 2026, a decrease of $218.4 million compared to the prior year.
  • A $100.0 million accelerated debt repayment was completed in January 2026, fully redeeming the senior secured notes due November 2026.
  • The Company retired $117.6 million aggregate principal of the senior secured notes due 2028 and senior notes due 2029 through debt repurchases at an approximate 6% discount to par.
  • Net cash provided by operating activities for the first six months of 2026 was $233.4 million compared to $287.5 million in the prior year period.
  • Free cash flow for the first six months of 2026 was $122.9 million compared to $160.6 million in the prior year period.

Analysis

Clarivate reported second-quarter revenue of $587.3 million, compared to $621.4 million in the second quarter of 2025. The Company attributed the reported decline primarily to inorganic divestitures and disposals. Organic revenues decreased 1.5%, although organic subscription revenues increased 0.7% and organic ACV grew 1.5% compared to June 30, 2025. The result points to continued progress in the subscription base, but lower transactional activity remained a meaningful offset.

Revenue mix continued to shift toward recurring offerings. Subscription revenues were $403.3 million and re-occurring revenues were $109.3 million, while recurring revenues increased 0.5% organically. Transactional revenues fell to $74.7 million, with the Company citing product group wind-downs within A&G, lower activity across all segments, and customer migrations to subscription offerings. Subscription revenue also reflected product group wind-downs within LS&H, despite organic growth from new sales and price increases.

GAAP profitability was materially affected by a $221.7 million non-cash goodwill impairment charge. Net loss was $268.6 million, or $0.42 per diluted share, compared with a net loss of $72.0 million, or $0.11 per diluted share, in the prior-year quarter. On a non-GAAP basis, adjusted net income was $123.1 million and adjusted diluted EPS was $0.19 per diluted share, compared with $123.3 million and $0.18 per diluted share, respectively. Adjusted EBITDA declined to $247.2 million from $261.6 million.

Cash generation was lower year over year. Second-quarter net cash provided by operating activities was $98.7 million and free cash flow was $44.0 million. For the first six months of 2026, operating cash flow was $233.4 million and free cash flow was $122.9 million, both below the prior-year period. Management nonetheless used cash flow and debt repurchases to reduce total debt outstanding to $4,251.5 million, including a $100.0 million accelerated repayment and retirement of $117.6 million aggregate principal through repurchases at an approximate 6% discount to par.

Clarivate reaffirmed its full-year 2026 outlook, including revenue of $2.30B to $2.42B, Adjusted EBITDA of $980M to $1.04B, adjusted diluted EPS of $0.70 to $0.80, and free cash flow of $365M to $435M. The outlook assumes no further acquisitions, divestitures, or unanticipated events. The key operating question is whether subscription and recurring growth can accelerate sufficiently to offset the decline in transactional revenues while the Company executes the previously announced Life Sciences & Healthcare segment divestiture.

Management, verbatim

The Value Creation Plan continues to drive meaningful progress, as we execute against our strategic priorities and strengthen Clarivate’s foundation for organic growth acceleration. During the quarter, we expanded organic recurring revenue, advanced our AI innovation roadmap, maintained disciplined cost management, and strengthened our balance sheet through deleveraging. Together, with the recently announced divestiture of the Life Sciences & Healthcare segment, these actions are creating a more focused company with greater financial flexibility, a higher recurring revenue mix, and a clear path to deliver long-term value to shareholders.

Matti Shem Tov, Chief Executive Officer

Our second quarter results reflect continued financial discipline and execution. In the first half of 2026, we expanded our profit margin and reduced debt by more than $200 million through strong free cash flow generation and opportunistic debt repurchases. Combined with our reaffirmed full-year outlook, these results demonstrate the resilience of our business model and our commitment to strengthening Clarivate’s financial profile while maintaining the flexibility to invest in our highest-value growth opportunities.

Jonathan Collins, Executive Vice President and Chief Financial Officer

Not in the filing

stated, not guessed
  • GAAP gross profit and gross margin for the second quarter of 2026
  • GAAP operating income or loss for the second quarter of 2026
  • Non-GAAP operating income for the second quarter of 2026
  • Actual Adjusted EBITDA margin for the second quarter of 2026
  • Tax rate for the second quarter of 2026
  • Reportable segment revenue and growth by operating segment
  • Prior-quarter comparisons for reported metrics
  • Cash and cash equivalents balance as of December 31, 2025
  • Prior-year total debt outstanding balance
  • Share repurchases, dividends, or other shareholder capital returns
  • Prior outlook needed to compare actual results with prior guidance

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about CLVT earnings dates

When is Clarivate's next earnings date?
AlphAI has no date for CLVT yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.